Behavioral Intervention for Obesity
(SWIFT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial requires that participants do not currently use glucagon-like peptide-1 (GLP-1) receptor agonists. Other medications are not mentioned, so it's unclear if you need to stop taking them.
What data supports the effectiveness of the treatment Weight Bias Internalization for obesity?
Is the behavioral intervention for obesity, known as weight bias internalization, safe for humans?
How is the treatment for Weight Bias Internalization different from other obesity treatments?
This treatment is unique because it focuses on addressing the internalized stigma and self-devaluation that people with obesity may feel, rather than just targeting weight loss. It aims to improve mental and social well-being by reducing negative self-perceptions, which can lead to better overall health outcomes.23458
What is the purpose of this trial?
Weight stigma and weight bias internalization (WBI) are common among adolescents at higher weight statuses. WBI is associated with negative physical and mental health outcomes. The current study aims to test an intervention for weight stigma and WBI combined with an evidence-based adolescent weight management program. Eligible adolescents (13-17) will be assigned by chance to one of two groups: 1) a 4-week intervention focused on weight stigma and WBI followed by a 16-week behavioral weight management program; or 2) a 4-week health information control (to include non-weight-related health promotion topics such as smoking and skin cancer prevention) followed by the same 16-week weight management program but without the WBI and weight stigma content. Study outcomes will be assessed at the 4-week and post-treatment (20 week) timepoints.
Research Team
Katherine Darling, PhD
Principal Investigator
The Miriam Hospital
Eligibility Criteria
This trial is for adolescents aged 13-17 who are dealing with obesity and may experience weight discrimination. They should be interested in managing their weight and willing to participate in a program that includes discussions on weight stigma. Specific eligibility criteria were not provided, so additional factors may apply.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo a 4-week intervention focused on weight stigma and WBI or a health information control, followed by a 16-week behavioral weight management program
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Weight Bias Internalization
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor